112 related articles for article (PubMed ID: 26740209)
21. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
[TBL] [Abstract][Full Text] [Related]
22. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
Hassan M; Ashraf Z; Abbas Q; Raza H; Seo SY
Interdiscip Sci; 2018 Mar; 10(1):68-80. PubMed ID: 27098808
[TBL] [Abstract][Full Text] [Related]
23. Virtual screening and experimental validation of novel histone deacetylase inhibitors.
Huang YX; Zhao J; Song QH; Zheng LH; Fan C; Liu TT; Bao YL; Sun LG; Zhang LB; Li YX
BMC Pharmacol Toxicol; 2016 Jul; 17(1):32. PubMed ID: 27443303
[TBL] [Abstract][Full Text] [Related]
24. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents.
Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H
Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787
[TBL] [Abstract][Full Text] [Related]
25. A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53.
Ghosh A; Sengupta A; Seerapu GPK; Nakhi A; Shivaji Ramarao EVV; Bung N; Bulusu G; Pal M; Haldar D
Biochem Biophys Res Commun; 2017 Jul; 488(3):562-569. PubMed ID: 28526414
[TBL] [Abstract][Full Text] [Related]
26. Hierarchical virtual screening of the dual MMP-2/HDAC-6 inhibitors from natural products based on pharmacophore models and molecular docking.
Wang Y; Yang L; Hou J; Zou Q; Gao Q; Yao W; Yao Q; Zhang J
J Biomol Struct Dyn; 2019 Feb; 37(3):649-670. PubMed ID: 29380672
[TBL] [Abstract][Full Text] [Related]
27. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
Kumar A; Dhar SK; Subbarao N
J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
[TBL] [Abstract][Full Text] [Related]
28. Docking and binding free energy calculations of sirtuin inhibitors.
Karaman B; Sippl W
Eur J Med Chem; 2015 Mar; 93():584-98. PubMed ID: 25748123
[TBL] [Abstract][Full Text] [Related]
29. Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols.
Ryckewaert L; Sacconnay L; Carrupt PA; Nurisso A; Simões-Pires C
Toxicol Lett; 2014 Sep; 229(2):374-80. PubMed ID: 24998427
[TBL] [Abstract][Full Text] [Related]
30. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.
Sixto-López Y; Bello M; Correa-Basurto J
J Biomol Struct Dyn; 2019 Feb; 37(3):584-610. PubMed ID: 29447615
[TBL] [Abstract][Full Text] [Related]
31. Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria.
Danishuddin M; Khan A; Faheem M; Kalaiarasan P; Hassan Baig M; Subbarao N; Khan AU
J Biomol Struct Dyn; 2014; 32(5):741-50. PubMed ID: 23600675
[TBL] [Abstract][Full Text] [Related]
32. Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach.
Dhanabalan AK; Kesherwani M; Velmurugan D; Gunasekaran K
J Mol Graph Model; 2017 Sep; 76():56-69. PubMed ID: 28710924
[TBL] [Abstract][Full Text] [Related]
33. Ligand and structure-based approaches for the identification of SIRT1 activators.
Vyas VK; Goel A; Ghate M; Patel P
Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.
Singh R; Pandey PN
Mol Biol Rep; 2015 Mar; 42(3):689-98. PubMed ID: 25663090
[TBL] [Abstract][Full Text] [Related]
35. In silico identification of potential inhibitors against shikimate dehydrogenase through virtual screening and toxicity studies for the treatment of tuberculosis.
Isa MA; Majumdar RS; Haider S
Int Microbiol; 2019 Mar; 22(1):7-17. PubMed ID: 30810932
[TBL] [Abstract][Full Text] [Related]
36. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
37. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
[TBL] [Abstract][Full Text] [Related]
38. Virtual screening approach of sirtuin inhibitors results in two new scaffolds.
Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M
Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698
[TBL] [Abstract][Full Text] [Related]
39. In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I.
Herrmann FC; Sivakumar N; Jose J; Costi MP; Pozzi C; Schmidt TJ
Molecules; 2017 Dec; 22(12):. PubMed ID: 29211037
[TBL] [Abstract][Full Text] [Related]
40. Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia.
Sinha S; Tyagi C; Goyal S; Jamal S; Somvanshi P; Grover A
J Biomol Struct Dyn; 2016 Oct; 34(10):2281-95. PubMed ID: 26510381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]